(A and B) Oncosphere number (A) and size (B) of KP and KPI cells grown
in non-adherent culture. Results represent mean ±SEM. n=3; *p<0.05
by Student’s t-test.
(C) Micrographs showing the size and morphology of representative KP and
KPI oncospheres. Scale bars represent 200 μm.
(D) Abundance of bronchioalveolar stem cells (BASCs) and alveolar type
II (AT2) cells in KP and KPI mouse lungs. Data expressed as mean % total lung
epithelial cells ±SEM. n=3.
(E) PCR of genomic DNA from KP and KPI BASC and AT2 cells after
transduction with Ad-Cre ex vivo. unrec.=unrecombined;
rec.=recombined; WT, wild-type. DNA from total lung epithelial cells in the
absence of Ad-Cre included as a control.
(F and G) Oncosphere growth of purified BASCs and AT2 cells from KP and
KPI mice transduced with Ad-Cre. Oncosphere numbers (F) and size (G) are shown
as mean ±SEM. n=3. *p<0.05 compared to KP by Student’s
t-test.
(H) Immunofluorescence of a bronchiolar lesion in a KP mouse stained for
CCSP (green, upper left panel), SPC (red; upper right panel) or merged image
CCSP, SPC and DAPI (blue, lower left panel) six weeks after induction of tumor
formation. Lower right panel shows H&E image of same lung region revealing
growth of bronchiolar hyperplasia from the affected terminal bronchiole. Scale
bars indicate 100 μm.
(I) Immunofluorescence of an alveolar lesion in KPI mouse stained for
CCSP (green, upper left panel), SPC (red; upper right panel) or merged image
CCSP, SPC and DAPI (blue, lower left panel) six weeks after induction of tumor
formation. Lower right panel shows H&E image of same lung region revealing
an alveolar lesion without bronchiolar involvement. Scale bars indicate 100
μm.
See also Figure
S1.